Literature DB >> 28225180

microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.

Mengyao Sun1, Xiaopeng Wang2, Chen Tu2, Shuang Wang2, Jianqiang Qu1, Shengxiang Xiao2.   

Abstract

MicroRNAs (miRNAs) play an increasingly important role in cancer growth by coordinately suppressing genes that control cell migration, proliferation, and invasion. The above results can be achieved through the regulation of gene expression by miRNAs by suppressing translation or the direct sequence-specific degradation of the targeted mRNA. In the present study, we indicate that the expression of miR-216b could be effectively repressed both in human melanoma tissues through a comparison with primary melanoma and in human melanoma cell lines through a comparison with a normal human keratinocyte line. Moreover, miR-216b induced a clear decrease in melanoma cell proliferation and migration in vitro. Forkhead box M1 (FOXM1) was confirmed as a target gene of miR-216b, and the overexpression of miR-216b markedly repressed the luciferase activity of reporter plasmids containing the FOXM1 3'-UTR (untranslated region). Furthermore, miR-216b suppressed melanoma cell growth in nude mice in vivo, with the effects of miR-216b overexpression on melanoma cell growth and proliferation reversed by FOXM1 overexpression. The results demonstrated that miR-216b is a tumor suppressor in melanoma, identified the FOXM1 signaling pathway as a target of miR-216b action, and suggested a potential therapeutic role for miR-216b in melanoma.
© 2017 International Federation for Cell Biology.

Entities:  

Keywords:  FOXM1; melanoma; miR-216b

Mesh:

Substances:

Year:  2017        PMID: 28225180     DOI: 10.1002/cbin.10754

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  8 in total

Review 1.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

2.  LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1.

Authors:  Yujia Shan; Jia Ma; Yue Pan; Jialei Hu; Bing Liu; Li Jia
Journal:  Cell Death Dis       Date:  2018-06-18       Impact factor: 8.469

3.  The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer.

Authors:  Mingfei Zuo; Lan Yao; Lijuan Wen; Jianfei Shen; Na Zhang; Tian Bai; Qicheng Huang
Journal:  World J Surg Oncol       Date:  2021-09-01       Impact factor: 2.754

Review 4.  FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.

Authors:  Cassie Liu; Carter J Barger; Adam R Karpf
Journal:  Cancers (Basel)       Date:  2021-06-19       Impact factor: 6.639

5.  Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun.

Authors:  Gang Huang; Jiongwei Pan; Zaiting Ye; Bingmu Fang; Wei Cheng; Zhuo Cao
Journal:  Oncotarget       Date:  2017-10-27

6.  MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1.

Authors:  Yanfen Yao; Qiaorong Li; Hong Wang
Journal:  Onco Targets Ther       Date:  2018-03-23       Impact factor: 4.147

7.  MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.

Authors:  Shanyang He; Bing Liao; Yalan Deng; Chang Su; Jiuling Tuo; Jun Liu; Shuzhong Yao; Lin Xu
Journal:  BMC Cancer       Date:  2017-10-04       Impact factor: 4.430

Review 8.  Regulation of the master regulator FOXM1 in cancer.

Authors:  Guo-Bin Liao; Xin-Zhe Li; Shuo Zeng; Cheng Liu; Shi-Ming Yang; Li Yang; Chang-Jiang Hu; Jian-Ying Bai
Journal:  Cell Commun Signal       Date:  2018-09-12       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.